LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs)

NCT01188928 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1152

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis Vulgaris

Interventions

DRUG: Calcipotriol plus betamethasone
DRUG: Betamethasone-17,21-dipropionate
DRUG: Calcipotriene
DRUG: Topical suspension vehicle

Sponsor

LEO Pharma